WO2025223528 - PYRIMIDO[6,1-A]ISOQUINOLIN-4-ONE DERIVATIVE
National phase entry is expected:
Publication Number
WO/2025/223528
Publication Date
30.10.2025
International Application No.
PCT/CN2025/091069
International Filing Date
24.04.2025
Title **
[English]
PYRIMIDO[6,1-A]ISOQUINOLIN-4-ONE DERIVATIVE
[French]
DÉRIVÉ DE PYRIMIDO[6,1-A]ISOQUINOLINE-4-ONE
[Chinese]
嘧啶并[6,1-a]异喹啉-4-酮衍生物
Applicants **
SUZHOU JUNJIAN YIFANG BIOPHARMACEUTICAL CO., LTD
Inventors
XIAO, Yong
CHEN, Guiping
Priority Data
202410516226.0
27.04.2024
CN
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
CNIPA
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 1605 | |
| EPO | Filing, Examination, Granting | 11653 | |
| Japan | Filing, Examination, Granting | 2051 | |
| South Korea | Filing, Examination, Granting | 1855 | |
| USA | Filing, Examination, Granting | 4740 |
Total:
21,904
Contact Us
Abstract[English]
A pyrimido[6,1-a]isoquinolin-4-one derivative, in particular a phosphate derivative thereof, a preparation method therefor and a use thereof as a phosphodiesterase (PDE) inhibitor. In particular, the present invention relates to a phosphamide compound of the pyrimido[6,1-a]isoquinolin-4-one derivative and a use thereof as an anti-inflammatory bronchodilator drug.[French]
L'invention concerne un dérivé pyrimido[6,1-a]isoquinoline-4-one, en particulier un dérivé phosphate correspondant, son procédé de préparation et son utilisation en tant qu'inhibiteur de phosphodiestérase (PDE). En particulier, la présente invention concerne un composé phosphamide du dérivé pyrimido[6,1-a]isoquinoline-4-one et son utilisation en tant que médicament bronchodilatateur anti-inflammatoire.[Chinese]
一类嘧啶并[6,1-a]异喹啉-4-酮衍生物，特别是它的磷酸酯类衍生物、其制备方法及其作为磷酸二酯酶(PDE)抑制剂的应用。尤其涉及嘧啶并[6,1-a]异喹啉-4-酮衍生物的磷酰胺化合物及其作为具有抗炎性支气管扩张药的应用。